|
|
|
| 07/30/2026 15:30 |
Presentation Material for the Three Months Ended June 30, 2026 |
| 07/30/2026 15:30 |
Consolidated Financial Results for the Three Months Ended June 30, 2026 |
| 06/25/2026 15:30 |
Business Model and Growth Strategy |
| 06/25/2026 15:30 |
Matters concerning controlling shareholders |
| 04/30/2026 15:30 |
Announcement regarding dif. between non-consolidated operating results and those for the previous fiscal year |
| 04/30/2026 15:30 |
Presentation Material for the Fiscal Year Ended March 31, 2026 |
| 04/30/2026 15:30 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 |
| 04/17/2026 15:30 |
Announcement regarding strategic collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed |
| 03/19/2026 15:30 |
Announcement regarding the transfer of fixed assets (trust beneficiary rights) owned by its consolidated subsidiary |
| 02/02/2026 15:30 |
Presentation Material for the Nine Months Ended December 31, 2025 |
| 02/02/2026 15:30 |
Consolidated Financial Results for the Nine Months Ended December 31, 2025 |
| 11/10/2025 15:30 |
Presentation Material for the Six Months Ended September 30, 2025 |
| 11/10/2025 15:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 |
| 11/05/2025 10:00 |
CUC Inc. and Dr. Yuji Okuno sign memorandum of understanding to advance access to catheter-based embolotherapy for musculoskeletal and inflammatory pa |
| 10/06/2025 17:00 |
Announcement regarding acquisition of DM Foot and Ankle Associates in Illinois |
| 09/12/2025 18:00 |
Announcement regarding determination of details of the issuance of tax-qualified stock options |
| 08/27/2025 15:30 |
Announcement regarding the issuance of tax-qualified stock options |
| 08/04/2025 15:30 |
Presentation Material for the quarter ended June 30, 2025 |
| 08/04/2025 15:30 |
Consolidated Financial Results for the Three Months Ended June 30, 2025 |
|